title: Polyphenols from green tea inhibit the growth of melanoma cells through inhibition of class I histone deacetylases and induction of DNA damage.
abstract: Melanoma is the leading cause of skin cancer-related deaths. We have examined the effect of green tea polyphenols (GTPs), a natural mixture of epicatechin monomers, on melanoma cancer cell growth and the molecular mechanism underlying these effects using different human melanoma cell lines as an in vitro model. Treatment of melanoma cell lines (A375, Hs294t, SK-Mel28 and SK-Mel119) with GTPs significantly inhibited the cell viability as well as colony formation ability of melanoma cells in a dose-dependent manner. These effects of GTPs were associated with a significant inhibition of histone deacetylase (HDAC) activity, reduction in the levels of class I HDAC proteins, enhancement of histone acetyltransferase (HAT) activity and induction of DNA damage, as detected by Comet assay, in melanoma cells. GTPs-induced decrease in the levels of class I HDAC proteins is mediated through proteasomal degradation. Valproic acid, an inhibitor of HDACs, exhibited a similar pattern of reduced viability and induction of death of melanoma cells. Treatment of A375 and Hs294t cells with GTPs resulted in a decrease in the levels of cyclins and cyclin dependent kinases of G1 phase of cell cycle whereas upregulated the levels of tumor suppressor proteins (Cip1/WAF1/p21, p16 and p53).
authors.affiliation: Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL, USA.
authors.forename: Ram
authors.initials: R
authors.lastname: Prasad
authors.affiliation: Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL, USA ; Environmental Health Sciences, University of Alabama at Birmingham, Birmingham, AL, USA ; Nutrition Obesity Research Center, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, USA ; Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA ; Birmingham Veterans Affairs Medical Center, Birmingham, AL, USA.
authors.forename: Santosh K
authors.initials: SK
authors.lastname: Katiyar
references.citation: Nutr Rev. 2007 Feb;65(2):88-94
references.pmid: 17345961
references.citation: Cancer Cell. 2004 May;5(5):455-63
references.pmid: 15144953
references.citation: Toxicol Appl Pharmacol. 2012 Aug 15;263(1):122-30
references.pmid: 22749965
references.citation: Annu Rev Pharmacol Toxicol. 2005;45:495-528
references.pmid: 15822187
references.citation: Nature. 2005 Jun 30;435(7046):1262-6
references.pmid: 15988529
references.citation: Epigenetics. 2008 May-Jun;3(3):164-71
references.pmid: 18487953
references.citation: Cancer Res. 2000 Sep 15;60(18):5165-70
references.pmid: 11016644
references.citation: Carcinogenesis. 2012 Feb;33(2):377-84
references.pmid: 22114073
references.citation: J Biol Chem. 1990 Oct 5;265(28):17174-9
references.pmid: 2211619
references.citation: Nat Genet. 2005 Apr;37(4):391-400
references.pmid: 15765097
references.citation: Front Biosci. 2006 May 01;11:1244-54
references.pmid: 16368510
references.citation: Int J Oncol. 2001 Jun;18(6):1307-13
references.pmid: 11351267
references.citation: Cancer Lett. 2008 Sep 28;269(1):7-17
references.pmid: 18462867
references.citation: Nat Clin Pract Oncol. 2005 Mar;2(3):150-7
references.pmid: 16264908
references.citation: Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19482-7
references.pmid: 18042714
references.citation: Breast Cancer Res Treat. 2005 Nov;94(1):11-6
references.pmid: 16172792
references.citation: J Biol Chem. 2006 May 12;281(19):13548-58
references.pmid: 16533812
references.citation: Epigenetics. 2008 Nov;3(6):300-9
references.pmid: 19029799
references.citation: PLoS One. 2011;6(6):e21410
references.pmid: 21731736
references.citation: Nat Rev Drug Discov. 2006 Sep;5(9):769-84
references.pmid: 16955068
references.citation: J Mol Biol. 1999 Apr 16;287(5):821-8
references.pmid: 10222191
references.citation: Cancer Metastasis Rev. 1995 Mar;14(1):3-15
references.pmid: 7606818
references.citation: Oncogene. 1995 Jul 20;11(2):211-9
references.pmid: 7624138
references.citation: Clin Cancer Res. 2004 Oct 15;10(20):6962-8
references.pmid: 15501975
references.citation: Carcinogenesis. 2011 Apr;32(4):537-44
references.pmid: 21209038
references.citation: Mol Cancer Ther. 2006 Feb;5(2):296-308
references.pmid: 16505103
references.citation: Epigenetics. 2013 Jan;8(1):54-65
references.pmid: 23221619
references.citation: J Nutr Biochem. 2007 May;18(5):287-96
references.pmid: 17049833
references.citation: Cell Prolif. 2000 Oct;33(5):261-74
references.pmid: 11063129
references.citation: Arch Biochem Biophys. 2011 Apr 15;508(2):152-8
references.pmid: 21094124
references.citation: Clin Epigenetics. 2011;3(1):4
references.pmid: 22247744
references.citation: Curr Pharm Biotechnol. 2007 Dec;8(6):388-400
references.pmid: 18289048
references.citation: Oncogene. 2000 Nov 23;19(50):5712-9
references.pmid: 11126357
references.citation: Prostate. 2004 May 1;59(2):177-89
references.pmid: 15042618
references.citation: PLoS One. 2011;6(10):e25224
references.pmid: 22022384
references.citation: Expert Opin Investig Drugs. 2007 Jul;16(7):1111-20
references.pmid: 17594194
references.citation: Photochem Photobiol Sci. 2006 Feb;5(2):243-53
references.pmid: 16465310